Amanote Research
Register
Sign In
Figure 2: Kaplan–Meier Curves of 1-Year, 3-Year, and 5-Year Event Free Survival From Recurrent Ventricular Tachycardia (VT)/ventricular Fibrillation (VF) Between ICM With LVEDV >158 mL and DCM.
doi 10.7717/peerj.5312/fig-2
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 1: Kaplan–Meier Curves of 1-Year, 3-Year, and 5-Year Event Free Survival From Recurrent Ventricular Tachycardia (VT)/ventricular Fibrillation (VF) Between ICM and DCM.
Figure 1: Kaplan-Meier Survival Curves (S(t)).
Table 4: Comparison of the Recurrent of VT/VF Between DCM Patients and ICM Patients With LV Volume and Function Like DCM Patients.
Figure S2: The Calibration Curves Predicting Overall Survival at (A) 3-Year and (B) 5-Year
Figure 5: Performance of Nine-lncRNA Prognostic Signature in Model Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
Figure 8: Performance of Nine-lncRNA Prognostic Signature in Validation Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
Figure 4: Kaplan–Meier Survival Curves for Five miRNAs Associated With Overall Survival.
Figure 7: The Kaplan–Meier Survival Curves in Validation Cohort.
Figure 4: The Kaplan–Meier Survival Curves in Model Cohort.
